A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity | MicrobiomeTrials← Back to trialsNCT07142707
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-09-03Est. Completion: 2026-10-30
Enrollment target: 124 participants Locations- MBX Biosciences Investigational Site, Doral, Florida, United States
- MBX Biosciences Investigational Site, Lexington, Kentucky, United States
- MBX Biosciences Investigational Site, Kansas City, Missouri, United States
- MBX Biosciences Investigational Site, Knoxville, Tennessee, United States
Other microbiome trials you might be interested in
Insulin ResistanceObesity
Background:
Obesity and related illnesses cause at least 2.8 million deaths each year worldwide. Few treatments exist f…
Bethesda, United StatesEst. completion Mar 1, 2030
Serious Mental Illness
This project addresses obesity in the population with SMI by evaluating a weight management program that is not only evi…
Pittsburgh, United StatesCompleted Sep 30, 2025
ENROLLING_BY_INVITATION
ExercisePhysical ActivityGamificationUniversity StudentCollege Student
The increasing incidence of cardiovascular disease (CVD) and related mortality is now recognized as a global emergency. …
Bursa, Turkey (Türkiye)Completed Mar 20, 2026